Answers are grounded in this paper and cite their sources.
Analysis shows urine pH ≤ 6 in 76% of women with urinary tract infections, indicating implications for treatment.
Introduction: Owing to its mechanism of action, Hiprex should be preferentially administered to those with stable urine pH 6 or less. Consequently, we sought to determine the common range of urine pH in a population of postmenopausal (PM) women affected by recurrent urinary tract infections (rUTIs) to understand the relevance of Hiprex for long-term rUTI management. Methods: Following Internal Review Board approval, a large, prospective database of PM women with uncomplicated rUTI was reviewed for concurrent data on urine pH and urine culture (UC) with bacterial species. Three groups were compared: a history of rUTI, current UTI, and no history of UTI (control). A χ 2 test analyzed association between a median pH of 6 or less by group. Urinary pH was also examined by bacterial species. Results: The final UC analysis included a total of 345 women (median age 70 years) who provided 1276 UCs (median 3 UCs). The rate of urine pH ≤ 6 was 76% (94/123) and 77% (255/332) in those with current UTI and a history of UTI, respectively. In the control group, urine pH was measured longitudinally (4 times) in 26 PM women (median age 70.5) and 65% (17/26) had a urine pH ≤ 6 (χ 2 P = .4). Minimal association was noted between low pH and bacterial species. Conclusions: Three-quarters of women with a history of uncomplicated rUTI, whether symptomatic at the time of the UC or not, had a urine pH ≤ 6. More than half of women with no history of UTI fell in that same category.
No takes yet. Share an insight, caveat, or question.
Pe et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: